The same study also demonstrated that NK cells created a Th17-polarizing cytokine environment by increasing the levels of IL-1β, TGF-β, TNF, and proinflammatory cytokines including MCP-1 and MIP-1α; IL-2 complex treatment reversed this effect, highlighting its therapeutic potential for MS (142). Here, IL2 is linked to myeloid sarcoma.